在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Macrophage-Derived Chemokine (MDC/CCL22) ELISA kit

  • 中文名稱(chēng):
    人巨噬細(xì)胞來(lái)源的趨化因子(MDC/CCL22)酶聯(lián)免疫試劑盒
  • 貨號(hào):
    CSB-E04660h
  • 規(guī)格:
    96T/48T
  • 價(jià)格:
    ¥3200/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人巨噬細(xì)胞來(lái)源的趨化因子(MDC/CCL22)酶聯(lián)免疫試劑盒(CSB-E04660h)為雙抗夾心法ELISA試劑盒,定量檢測(cè)血清、血漿、組織培養(yǎng)上清液、組織勻漿樣本中的CCL22含量。CCL22是一個(gè)靶點(diǎn)。它在免疫調(diào)節(jié)等生理過(guò)程里有重要作用。研究發(fā)現(xiàn),CCL22與多種疾病相關(guān),如腫瘤等,其機(jī)制可能是通過(guò)與相應(yīng)受體結(jié)合,影響免疫細(xì)胞的遷移、活化等,進(jìn)而參與疾病的發(fā)生發(fā)展。對(duì)它的研究或?yàn)橄嚓P(guān)疾病治療帶來(lái)新思路。試劑盒檢測(cè)范圍為15.625 pg/mL-1000 pg/mL,靈敏度為10.324 pg/mL。適用于體外定量檢測(cè)多種生物樣本中的蛋白表達(dá)量,能夠滿足炎癥機(jī)制研究、藥物干預(yù)效果評(píng)估及生物標(biāo)志物篩選等科研需求。例如,可通過(guò)檢測(cè)細(xì)胞因子誘導(dǎo)后的巨噬細(xì)胞培養(yǎng)上清中MDC/CCL22分泌水平,探索免疫調(diào)控通路;或分析腫瘤組織勻漿中趨化因子濃度與免疫細(xì)胞浸潤(rùn)的相關(guān)性,為疾病機(jī)制研究提供可靠工具。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見(jiàn)產(chǎn)品說(shuō)明書(shū)。
  • 別名:
    A 152E5.1 ELISA Kit; ABCD 1 ELISA Kit; ABCD1 ELISA Kit; C C motif chemokine 22 ELISA Kit; CC chemokine STCP 1 ELISA Kit; CC chemokine STCP-1 ELISA Kit; ccl 22 ELISA Kit; Ccl22 ELISA Kit; CCL22_HUMAN ELISA Kit; Chemokine (C C motif) ligand 22 ELISA Kit; DC/B CK ELISA Kit; DCBCK ELISA Kit; Macrophage-derived chemokine ELISA Kit; MDC ELISA Kit; MDC(1-69) ELISA Kit; MDC(7-69) ELISA Kit; MGC34554 ELISA Kit; SCYA22 ELISA Kit; Small inducible cytokine subfamily A (Cys Cys) member 22 ELISA Kit; Small inducible cytokine subfamily A; member 22 ELISA Kit; Small-inducible cytokine A22 ELISA Kit; STCP 1 ELISA Kit; STCP1 ELISA Kit; Stimulated T cell chemotactic protein 1 ELISA Kit; Stimulated T-cell chemotactic protein 1 ELISA Kit
  • 縮寫(xiě):
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類(lèi)型:
    serum, plasma, cell culture supernates, tissue homogenates
  • 檢測(cè)范圍:
    15.625 pg/mL-1000 pg/mL
  • 靈敏度:
    10.324 pg/mL
  • 反應(yīng)時(shí)間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測(cè)波長(zhǎng):
    450 nm
  • 研究領(lǐng)域:
    Immunology
  • 測(cè)定原理:
    quantitative
  • 測(cè)定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%      
    Three samples of known concentration were tested twenty times on one plate to assess.  
    Inter-assay Precision (Precision between assays): CV%<10%      
    Three samples of known concentration were tested in twenty assays to assess.    
                 
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human MDC in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
      Sample Serum(n=4)  
    1:1 Average % 86  
    Range % 82-95  
    1:2 Average % 92  
    Range % 85-101  
    1:4 Average % 100  
    Range % 94-112  
    1:8 Average % 93  
    Range % 85-98  
  • 回收率:
    The recovery of human MDC spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range  
    Serum (n=5) 85 80-93  
    EDTA plasma (n=4) 89 85-98  
                 
                 
  • 標(biāo)準(zhǔn)曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    pg/ml OD1 OD2 Average Corrected  
    1000 2.534 2.421 2.478 2.349  
    500 1.956 1.766 1.861 1.732  
    250 1.147 1.087 1.117 0.988  
    125 0.602 0.611 0.607 0.478  
    62.5 0.341 0.331 0.336 0.207  
    31.25 0.245 0.262 0.254 0.125  
    15.625 0.198 0.201 0.200 0.071  
    0 0.134 0.124 0.129    
  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 最新研究進(jìn)展:
        CCL22,全稱(chēng)為C-C motif chemokine ligand 22,是一種細(xì)胞因子,屬于趨化因子家族。CCL22在體內(nèi)的生物學(xué)功能主要是調(diào)節(jié)免疫細(xì)胞的遷移,特別是對(duì)Th2淋巴細(xì)胞具有吸引作用,因此被認(rèn)為在過(guò)敏反應(yīng)、哮喘等炎癥性疾病中發(fā)揮重要作用。近年來(lái)的研究表明,CCL22不僅在炎癥反應(yīng)中起作用,還可能參與腫瘤的發(fā)生、發(fā)展和預(yù)后,成為腫瘤免疫治療中一個(gè)備受關(guān)注的靶點(diǎn)。目前,研究人員正在探索針對(duì)CCL22的治療策略以及其在腫瘤免疫療法中的應(yīng)用前景。
     
  • 功能:
    May play a role in the trafficking of activated/effector T-lymphocytes to inflammatory sites and other aspects of activated T-lymphocyte physiology. Chemotactic for monocytes, dendritic cells and natural killer cells. Mild chemoattractant for primary activated T-lymphocytes and a potent chemoattractant for chronically activated T-lymphocytes but has no chemoattractant activity for neutrophils, eosinophils, and resting T-lymphocytes. Binds to CCR4. Processed forms MDC(3-69), MDC(5-69) and MDC(7-69) seem not be active.
  • 基因功能參考文獻(xiàn):
    1. MDC might serve as a marker of pharmacological therapy response in major depressive disorder PMID: 28898872
    2. blood CCL22 levels were positively associated with IgE sensitization at age 2. A high cord blood CCL22/CXCL10 chemokine ratio was significantly associated with a higher risk of allergic sensitization at age 3. PMID: 27863395
    3. Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 signaling axis. PMID: 28039457
    4. Elevations in serum MDC and BLC were independently associated with the significant risk of early stage lung adenocarcinoma, even in non-smokers and in stage IA patients. PMID: 27811371
    5. CCL22 plays an important role in supporting gastric cancer development presumably by increasing the percentage of regulatory T cells in the tumor microenvironments. CCL22 levels in sera have a predictive value for gastric cancer peritoneal metastasis and the early recurrence. PMID: 28501127
    6. The CCL22-mediated enhancement of antitumor responses is however not due to conversion, but rather to redirection of existing regulatory T cells to the site of cutaneous overexpression. PMID: 27634754
    7. CCL22 and IL-37 with a co-localization in non-small cell lung cancer A549 cells inhibited the proliferation and epithelial-mesenchymal transition process PMID: 27499437
    8. Our results demonstrate that CCL22 is expressed in human placenta. Decidual expression was only observed in miscarriage conditions and correlates with Treg infiltration. PMID: 25922986
    9. Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris. PMID: 26093920
    10. type I IFN blocks the regulatory T cell-attracting chemokine CCL22 and thus helps limit the recruitment of regulatory T cells to tumors PMID: 26432403
    11. First-episode psychosis patients had higher serum CCL22, which decreased substantially following antipsychotic treatment. PMID: 25970596
    12. Elevated levels of CCL22 found in the ascites could create a chemokine gradient aiding in Treg cells migration. Increased Tregs percentage in the local microenvironment of ovarian cancer might be an important mechanism of immunosuppression. PMID: 25647263
    13. Circulating CCL22 levels are related to both glioma risk and survival duration independent of age, histology, grade and IDH mutation status. CCL22 should be considered a marker of immune status with potential prognostic value PMID: 25604093
    14. CCL22 is a novel mediator of lung inflammation following hemorrhage and resuscitation PMID: 25136780
    15. CCR4 C1014T and CCL22 C16A genetic variations were neither associated with the risk, nor with the progression of colorectal cancer in Iranian population PMID: 25148803
    16. The serum CCL22 levels were affected by genetic variations at SNP rs223818. Accordingly, SNP rs223818 may play a role in the susceptibility to breast cancer. PMID: 25722218
    17. Sesamin suppressed lipopolysaccharide induced CCL22 expression in monocytes through the ER/PPAR-a, the MAPK-p38 pathway, the NFkB-p65 pathway and the epigenetic regulation by suppressing histone H3/H4 acetylation in the CCL22 promoter region. PMID: 25117529
    18. CCL22 could be an immune marker in ANCA-associated vasculitis. PMID: 25352172
    19. Suggest that lower CCL22 levels may play an important role in the pathogenesis of multiple sclerosis in women. PMID: 24254331
    20. CCL22 is an antimicrobial protein with bacteriocidal activity against E. coli and S. aureus. PMID: 12949249
    21. genetic polymorphism is not associated with breast carcinoma in Southern Iranian population PMID: 23268288
    22. both CCL22 and TGF-beta1 are candidate chemoattractants for intratumoral Foxp3 (+)Tregs infiltration; however, unlike the later, CCL22 is an independent prognostic predictor of BC patients. PMID: 24124553
    23. Autistic children had significantly higher serum levels of MDC than healthy controls PMID: 23782855
    24. Data suggest that decreased levels of plasmatic CCL22 may contribute to CD4(+) lymphopaenia. PMID: 23265706
    25. lymph node metastasis of CCR4(+) HNSCC is promoted by CCL22 in an autocrine or M2-like macrophage-dependent paracrine manner. PMID: 23180648
    26. High cord blood levels of the Th2 related chemokine CCL22 were significantly associated with high total- IgE levels during the first 6 years of life, but not with specific sensitization, asthma, eczema or allergic rhinitis. PMID: 23106659
    27. findings suggest that HBV infection and activity of the TGF-beta-miR-34a-CCL22 axis serve as potent etiological factors to predispose hepatocellular carcinoma patients for the development of portal vein tumor thrombus PMID: 22975373
    28. results suggested that suppression of the CCL22 gene using Salmonella induced anti-inflammatory effects PMID: 21823987
    29. Data suggest that variants of C-C motif chemokine 22 (CCL22) play a role in susceptibility to atopic dermatitis (AD) in a gain-of-function manner. PMID: 22125604
    30. chemokine CCL22 may have a role in abdominal aortic aneurysm PMID: 20348247
    31. CCL22 may be responsible for the infiltration of CD4(+)CD25(high) T cells into the pleural space of patients with tuberculous pleurisy. PMID: 20337996
    32. Plasma concentration of CCL22 correlates with the frequency of circulating CD4-positive FoxP3-positive (CD4+FoxP3+) regulatory T cells (Tregs) in human T-lymphotropic virus (HTLV) type 1-infected subjects. PMID: 20525891
    33. Endocrine disrupting chemicals suppressed CCL22 and IP-10 levels in cultured monocytes via, at least in part, the MKK1/2-ERK MAPK pathway and histone H4 acetylation. PMID: 19756997
    34. Data show that MDC/CCL22 is present in the synovial membrane of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients and in synovial fluid of patients with RA and PsA, which would enable migration of CCR4 expressing memory cells. PMID: 19942450
    35. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22, suggesting a vicious circle, leading to the progressive accumulation of the neoplastic cells. PMID: 11981828
    36. Neither MDC release nor MDC mRNA was detected in any of the 3 types of fibroblasts stimulated with any of the cytokines examined. PMID: 12642832
    37. Serum levels of TARC and MDC in atopic dermatitis patients were significantly higher than those found in normal controls. PMID: 15113590
    38. CCL22 induced accumulation of phosphatidylinositol-(3,4,5)-trisphosphate in the leukemic T cell line CEM. CCL22 also had the ability to chemoattract human Th2 cells and CEM cells in a pertussis toxin-sensitive manner. PMID: 15187160
    39. CCL17 and CCL22, which are constitutively produced by immature DCs, mediate both T cell polarization and attraction. PMID: 15210758
    40. Elevated bronchial mucosal expression of MDC/CCL22 is implicated in asthma pathogenesis; its action is partly through selective development and retention, or recruitment of T helper type 2, not Th1, receptor-bearing cells. PMID: 15944327
    41. MDC/CCL22 has a role in inhibiting progression of lung cancer PMID: 16453150
    42. These data suggest that the CCL22 level produced by monocyte derived dendritic cells thus reflects the disease activity of Atopic dermatitis (AD) and it may also play an important role regarding the production of CCL22 in the pathogenesis of AD. PMID: 17008059
    43. A trend towards a decreased allelic frequency of the A allele of the CCL22 C/A SNP as well as of the T allele of the CCL17 C/T SNP was found in MS patients compared with controls. PMID: 17967467
    44. HTLV-1-infected T cells produce CCL22 through Tax and selectively interact with CCR4+CD4+ T cells, resulting in preferential transmission of HTLV-1 to CCR4+CD4+ T cells. PMID: 18178833
    45. MDC/CCL22 is likely to play a role in the development of multiple sclerosis in females only, possibly influencing the intracerebral recruitment of Th2 cells, which produce anti-inflammatory cytokines PMID: 18208895
    46. Significantly higher CCL22 expression is associated with gastric cancer PMID: 18224687
    47. although IE86 does repress the UL144-mediated activation of a synthetic NFkB promoter, it is unable to block UL144-mediated activation of the CCL22 promoter, and this lack of responsiveness to IE86 appears to be regulated by binding of CREB. PMID: 18287226
    48. serum CCR4 ligands (CCL17 and CCL22)may be useful inflammatory markers for assessing atopic dermatitis severity in children PMID: 18435706
    49. Development of allergic disease is associated with a more marked Th2-like deviation already at birth, shown as increased levels of cord blood IgE and MDC (CCL22) and higher ratios of MDC (CCL22) to IP-10 (CXCL10) and I-TAC (CXCL11). PMID: 19175890
    50. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. PMID: 19244125

    顯示更多

    收起更多

  • 亞細(xì)胞定位:
    Secreted.
  • 蛋白家族:
    Intercrine beta (chemokine CC) family
  • 組織特異性:
    Highly expressed in macrophage and in monocyte-derived dendritic cells, and thymus. Also found in lymph node, appendix, activated monocytes, resting and activated macrophages. Lower expression in lung and spleen. Very weak expression in small intestine. I
  • 數(shù)據(jù)庫(kù)鏈接:

    HGNC: 10621

    OMIM: 602957

    KEGG: hsa:6367

    STRING: 9606.ENSP00000219235

    UniGene: Hs.534347



主站蜘蛛池模板: 久青青视频在线观看久| 99日本精品永久免费久久| 成人麻豆亚洲综合无码精品| 国产av一二三无码影片| 免费无码精品黄av电影| 欧美午夜精品久久久久久浪潮| 婷婷丁香五月六月综合激情啪| 天堂资源在线官网| 麻豆一区二区99久久久久 | 国产在线观看超清无码视频一区二区 | 精品国产成人高清在线观看| 国产二级一片内射视频插放| 中文字幕精品一区二区精品| 丁香五月开心婷婷激情综合| 无码中文字幕av免费放dvd| 无码国内精品人妻少妇蜜桃视频 | 精品国产一区二区av麻豆不卡| 蜜臀少妇人妻在线| 女人被狂躁的高潮免费视频| 少妇放荡的呻吟干柴烈火动漫| 免费人成在线观看成人片| 69国产成人精品午夜福中文 | 国产一卡二卡三卡四卡视频版| 国产美女精品一区二区三区| 日本成熟老妇乱| 999久久久无码国产精品| 狠狠色色综合网站| 东京热一区二区三区无码视频| 色综合天天无码网站| 视频久re精品在线观看| 人妻av中文系列| 久久久天堂国产精品女人| 国产成人精品一区二区不卡| 99久久精品国产第一页| 国产精品无码无需播放器| 免费h动漫无码网站| 亚洲精品色情app在线下载观看| 亚洲精品蜜夜内射| 国产成人综合色视频精品 | av毛片无码中文字幕不卡 | 大伊香蕉在线精品视频75|